What Has Been the Progress and Growth of the Veterinary Intravenous IV Solutions Market in Recent Years?
The veterinary intravenous iv solutions market has seen considerable growth due to a variety of factors.
• The market size for veterinary intravenous (IV) solutions has experienced robust growth in the recent past. The growth from $1.5 billion in 2024 to an anticipated $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%, is predicted.
The significant growth noted in the historic period could be due to factors such as the surge in the number of veterinary clinics, an increase in dehydration cases, expansion in livestock farming, an increase in the number of household pets, and growth in veterinary diagnostic methods.
What Is The Expected Growth In The Veterinary Intravenous IV Solutions Market Size Evolve over the Forecast Period?
The veterinary intravenous iv solutions market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of veterinary intravenous (IV) solutions is projected to witness significant expansion in the coming years, reaching $2.19 billion by 2029 with a compound annual growth rate (CAGR) of 7.8%.
Factors contributing to the predicted growth during the forecast period include increased uptake of pet insurance, escalation in animal healthcare spending, heightened awareness regarding animal healthcare, growing instances of animal diseases, and expanded pet insurance coverage. Some of the identifiable trends for this period encompass technological advancements, variation in product formulations, incorporation of telemedicine, enhanced veterinary intravenous (IV) delivery systems, and the emergence of intelligent veterinary intravenous (IV) systems.
What Main Forces Are Fueling Expansion In The Veterinary Intravenous IV Solutions Market?
The rising incidences of various animal diseases are anticipated to stimulate the expansion of the veterinary intravenous (IV) solutions market. Animal diseases, which encompass health conditions or disorders impacting animals, include common diseases like anthrax, leptospirosis, rabies, canine distemper, heartworm disease, among others. The escalating prevalence of these diseases can be attributed to factors such as extensive farming activities, wildlife intrusion, and resistance to antibiotics. Veterinary intravenous solutions serve a vital role in rehydrating animals hit by diseases causing dehydration, like gastroenteritis or severe infections, thereby ensuring total hydration and promoting holistic health outcomes. For example, AVMA Publications, the publishing wing of the American Veterinary Medical Association based in the U.S, revealed in July 2024 that approximately 345 domestic animals were confirmed with rabies in 2022, indicating a 10.9% increase from the 311 incidents reported in 2021. Hence, the accelerating prevalence of diverse animal diseases is facilitating the growth of the veterinary intravenous (IV) solutions market.
What Are The Primary Segments In The Global Veterinary Intravenous IV Solutions Market?
The veterinary intravenous (IV) solutions market covered in this report is segmented –
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition
2) By Animal Type: Companion Animals, Production Animals
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users
Subsegments:
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer's Solution, Dextrose in Water (D5W), Ringer's Solution, Balanced Electrolyte Solutions
2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)
3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins
4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions
Pre-Book The Veterinary Intravenous IV Solutions Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Veterinary Intravenous IV Solutions Market?
Key players within the veterinary intravenous (IV) solutions market are concentrating on the evolution of superior products such as fluoroquinolones to enhance their effectiveness and safety levels. Fluoroquinolones represent a potent category of antibiotics employed in both human and veterinary medicine for controlling various bacterial infections, provided their usage is well-managed to curb resistance and side effects risks. For instance, Elanco, a pharmaceutical firm based in the U.S., unveiled Pradalex in April 2024. Pradalex is a pradofloxacin injection solution greenlit by the US Food and Drug Administration (FDA), a health organization based in the U.S. The clearance for use in swines is for addressing swine respiratory disease (SRD) linked with pathogens like bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. As a 3rd generation fluoroquinolone, Pradalex is deemed as an extremely critical antimicrobial. The labeling of the medicine highlights that it should be designated only when other non-fluoroquinolone therapeutic alternatives have been considered.
Who Are the Key Players In The Veterinary Intravenous IV Solutions Market?
Major companies operating in the veterinary intravenous (IV) solutions market are:
• Merck & Co. Inc.
• Baxter International Inc.
• Zoetis Inc.
• Fresenius Kabi AG
• Elanco Animal Health Incorporated
• B. Braun Melsungen AG
• Virbac SA
• Dechra Pharmaceuticals PLC
• Vetoquinol SA
• Norbrook Laboratories Limited
• Ceva Santé Animale
• Revival Animal Health Inc.
• Aromor Animal Health
• Jorgensen Laboratories LLC
• Pharmacosmos AS
• Sykes Veterinary International Pty Ltd.
• Rusoma Laboratories Private Limited
• Patterson Companies Inc.
• NexGen Veterinary
• Soxa Formulations & Research Pvt. Ltd
What Is The Most Dominant Region In The Veterinary Intravenous IV Solutions Market?
North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
